{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:47:50Z","timestamp":1782744470097,"version":"3.54.5"},"reference-count":0,"publisher":"International Institute of Anticancer Research","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anticancer Res"],"accepted":{"date-parts":[[2026,5,13]]},"published-print":{"date-parts":[[2026,7]]},"DOI":"10.21873\/anticanres.18270","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:30:26Z","timestamp":1782743426000},"page":"4107-4118","source":"Crossref","is-referenced-by-count":0,"title":["Real-world Comparison of Avelumab Maintenance and Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma"],"prefix":"10.21873","volume":"46","author":[{"given":"TSUNG-HAN","family":"YEN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHIAN-SHIANG","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHAUN-SHU","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHENG-CHE","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHIA-YEN","family":"LIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHENG-CHUN","family":"HUNG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GU-SHUN","family":"LAI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JIAN-RI","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHENG-KUANG","family":"YANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YI-CHING","family":"LIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"9336","published-online":{"date-parts":[[2026,6,29]]},"container-title":["Anticancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.21873\/anticanres.18270","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:30:32Z","timestamp":1782743432000},"score":1,"resource":{"primary":{"URL":"http:\/\/ar.iiarjournals.org\/lookup\/doi\/10.21873\/anticanres.18270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":0,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,6,29]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.21873\/anticanres.18270"],"URL":"https:\/\/doi.org\/10.21873\/anticanres.18270","relation":{},"ISSN":["0250-7005","1791-7530"],"issn-type":[{"value":"0250-7005","type":"print"},{"value":"1791-7530","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]}}}